These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 831472)

  • 1. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of phlebitis associated with cefazolin and cephalothin.
    Cole DR
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):75-7. PubMed ID: 789268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phlebitis associated with the intravenous use of cephalothin and cephapirin.
    Sorrentino AP; Haughey EJ; Cronin DW; Bohen LN
    Am J Hosp Pharm; 1976 Jul; 33(7):642-4. PubMed ID: 941915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inline filtration of intravenous infusions on the incidence of thrombophlebitis.
    Chamberland ME; Lyons RW; Brock SM
    Am J Hosp Pharm; 1977 Oct; 34(10):1068-70. PubMed ID: 920740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filtration and infusion phlebitis: a double-blind prospective clinical study.
    DeLuca PP; Rapp RP; Bivins B; McKean HE; Griffen WO
    Am J Hosp Pharm; 1975 Oct; 32(10):1001-7. PubMed ID: 1103617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis.
    Evans WE; Barker LF; Simone JV
    Am J Hosp Pharm; 1976 Nov; 33(11):1160-3. PubMed ID: 998633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inline filtration on postinfusion phlebitis.
    Maddox RR; John JF; Brown LL; Smith CE
    Clin Pharm; 1983; 2(1):58-61. PubMed ID: 6883931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of filtration on complications of postoperative intravenous therapy.
    Rusho WJ; Bair JN
    Am J Hosp Pharm; 1979 Oct; 36(10):1355-6. PubMed ID: 507079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.
    Schroeder HG; DeLuca PP
    Am J Hosp Pharm; 1976 Jun; 33(6):543-6. PubMed ID: 1274972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of buffering on the incidence and severity of cephalothin-induced phlebitis.
    Lipman AG
    Am J Hosp Pharm; 1974 Mar; 31(3):266-8. PubMed ID: 4819440
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.
    Lane AZ; Taggart JG; Iles RL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):234-5. PubMed ID: 4790563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of side effects of intravenous cephapirin and cephalothin with special reference to the incidence of phlebitis].
    Watanabe A; Oizumi K; Konno K
    Jpn J Antibiot; 1983 Dec; 36(12):3395-8. PubMed ID: 6674550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinfusion phlebitis associated with a syringe system versus minibags.
    Rapp RP; Powers P; Tolbert V; Piecoro JJ; Record KE
    Clin Pharm; 1986 May; 5(5):408-11. PubMed ID: 3720211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA; Plis JM; Clay C; Sylvan L
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1976 Apr; 9(4):646-8. PubMed ID: 1267438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agents.
    Garrelts JC; Ast D; LaRocca J; Smith DF; Peterie JD
    Clin Pharm; 1988 Oct; 7(10):760-5. PubMed ID: 3233896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
    Inagaki J; Bodey GP
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):37-43. PubMed ID: 4632504
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.
    Berger S; Ernst EC; Barza M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):575-9. PubMed ID: 5053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics.
    Meguro S; Kuraishi Y; Kobayashi T; Chinen T; Ikeda K; Nagata T; Ichiba K; Abe M
    Jpn J Antibiot; 1980 Nov; 33(11):1163-5. PubMed ID: 7241794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of phlebitis produced by cephalothin infusions with buffered and unbuffered diluents.
    Carrizosa J; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1974 Feb; 5(2):192-3. PubMed ID: 4840431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.